All-in-one device uses microwave power for defense, medicine
(Press-News.org) WEST LAFAYETTE, Ind. - An invention from Purdue University innovators may provide a new option to use directed energy for biomedical and defense applications.
The Purdue invention uses composite based nonlinear transmission lines (NLTLs) for a complete high-power microwave system, eliminating the need for multiple auxiliary systems. The interest in NLTLs has increased in the past few decades because they offer an effective solid-state alternative to conventional vacuum-based, high-power microwave generators that require large and expensive external systems, such as cryogenic electromagnets and high-voltage nanosecond pulse generators.
NLTLs have proven effective for applications in the defense and biomedical fields. They create directed high-power microwaves that can be used to disrupt or destroy adversary electronic equipment at a distance. The same technology also can be used for biomedical devices for sterilization and noninvasive medical treatments.
"We created a new NLTL device that reduces the bulkiness of current options and offers new opportunities to protect our country and help patients in a man-portable form factor," said Andrew Fairbanks, a Ph.D. student and graduate research assistant in Purdue's College of Engineering. "In engineering, we are concerned about size, weight, power and cost. Our invention helps address all of these."
Allen Garner, an associate professor of nuclear engineering, led the Purdue team. The researchers created a novel device using composite-based NLTLs as complete high-power microwave systems, encompassing high-voltage pulse and high-power microwave formation. The Purdue device combines the elements of traditional NLTLs into a composite-based system and eliminates typical bulky auxiliary equipment.
The system is charged using a DC high-voltage supply and discharged using a high-voltage, gas-based switch. The system eliminates the need for external pulse generation and is more rugged due to the solid-state construction.
This work was supported by the Office of Naval Research (Grant No. N00014-18-1-2341).
Fairbanks presented the Purdue technology in March at the Directed Energy Professional Society annual Science and Technology Symposium.
The innovators worked with the Purdue Research Foundation Office of Technology Commercialization to patent their technology.
"It has been very beneficial to our team and our advancement of this technology to have OTC here at Purdue," Fairbanks said. "OTC and other resources from Purdue Research Foundation provide support to take our technology and push it out to the world through patenting and commercialization."
The innovators and OTC are looking for partners to continue developing their technology. For more information on licensing and other opportunities, contact Matthew Halladay of OTC at email@example.com and mention track code 69397.
About Purdue Research Foundation Office of Technology Commercialization
The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university's academic activities through commercializing, licensing and protecting Purdue intellectual property. The office is located in the Convergence Center for Innovation and Collaboration in Discovery Park District, adjacent to the Purdue campus. In fiscal year 2020, the office reported 148 deals finalized with 225 technologies signed, 408 disclosures received and 180 issued U.S. patents. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact firstname.lastname@example.org for more information.
About Purdue University
Purdue University is a top public research institution developing practical solutions to today's toughest challenges. Ranked the No. 5 Most Innovative University in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at purdue.edu.
ELSE PRESS RELEASES FROM THIS DATE:
Doublespeak, or the use of euphemisms to sway opinion, lets leaders avoid the reputational costs of lying while still bringing people around to their way of thinking, a new study has found.
Researchers at the University of Waterloo found that the use of agreeable euphemistic terms biases people's evaluations of actions to be more favourable. For example, replacing a disagreeable term, "torture," with something more innocuous and semantically agreeable, like "enhanced interrogation."
"Like the much-studied phenomenon of 'fake news,' manipulative language can serve as a tool for misleading the public, doing so not with falsehoods but rather with the strategic use of euphemistic language," said Alexander Walker, lead author of the study and a PhD candidate in cognitive ...
Single-cell transcriptomic methods allow scientists to study thousands of individual cells from living organisms, one-by-one, and sequence each cell's genetic material. Genes are activated differently in each cell type, giving rise to cell types such as neurons, skin cells and muscle cells.
Single-cell transcriptomics allows scientists to identify the genes that are active in each individual cell type, and discover how these genetic differences change cellular identity and function. Careful study of this data can allow new cell types to be discovered, ...
Researchers funded by the National Institutes of Health have developed a test to evaluate the expressive language skills of people with Down syndrome, a condition resulting from an extra copy or piece of chromosome 21. Expressive language is the use of words to convey meaning to others. Language delays are common in people with Down syndrome, and the study authors believe their test provides a more effective way to evaluate prospective language interventions, compared to current evaluation methods.
The study was conducted by Angela Thurman, Ph.D., of the University of California, Davis, and ...
Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center.
In a paper published in the journal PNAS last month, CU Cancer Center members Mayumi Fujita, MD, PhD, Angelo D'Alessandro, PhD, Morkos Henen, PhD, MS, Beat Vogeli, PhD, Eric Pietras, PhD, James DeGregori, PhD, Carlo Marchetti, PhD, and Charles Dinarello, MD, along with Isak Tengesdal, MS, a graduate student in the Division of Infectious Diseases at the University of Colorado School of Medicine, detail their work on NLRP3, an intracellular complex that has been found to participate in melanoma-mediated inflammation, leading to tumor growth and progression. By ...
ZANZIBAR CITY (April 7, 2021) - A new study revealed that a drastic reduction of deaths of one of Africa's rarest primates, the Zanzibar red colobus (Piliocolobus kirkii), followed the installation of four speedbumps along a stretch of road where the species frequently crossed.
Zanzibar red colobus are found only in the Zanzibar archipelago and classified as Endangered by the IUCN Red List. Reliant on Unguja Island's forests for their survival, around half of the species population is found in Jozani-Chwaka Bay National Park.
In the study, published ...
Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue. This is according to a study published in the journal JAMA, conducted by researchers at Danderyd Hospital and Karolinska Institutet in Sweden.
Since spring 2020, researchers at Danderyd Hospital and Karolinska Institutet have conducted the so-called COMMUNITY study, with the main purpose of examining immunity after COVID-19. In the first phase of the study in spring 2020, blood samples were collected from 2,149 employees at Danderyd Hospital, of whom about 19 percent had antibodies against SARS-CoV-2. Blood samples have since ...
With a lethal, airborne virus spreading fast, hospitals had to change how they treated patients and policies for how caregivers provided that treatment. But for maternity patients and nurses some of those changes had negative outcomes, according to a new University of Washington study.
"We found that visitor restrictions and separation policies were harming families and nurses. The effects for patients included loneliness, isolation and mistrust, while nurses described mistrust and low morale," said Molly Altman, lead author of the study and assistant professor in the UW School of Nursing.
Importantly, Altman added, both nurses and patients described how COVID "amplified existing ...
LA JOLLA--(April 7, 2021) When cells are stressed, chemical alarms go off, setting in motion a flurry of activity that protects the cell's most important players. During the rush, a protein called Parkin hurries to protect the mitochondria, the power stations that generate energy for the cell. Now Salk researchers have discovered a direct link between a master sensor of cell stress and Parkin itself. The same pathway is also tied to type 2 diabetes and cancer, which could open a new avenue for treating all three diseases.
"Our findings represent the earliest step in Parkin's alarm response that anyone's ever found by a long shot. ...
New medicines for people who have diabetes seem to pop up all the time. Drugs that help the body break down carbohydrates, drugs that increase excretion of glucose in the urine, drugs that help muscles respond to insulin and drugs that stimulate the pancreas to produce it -- the list of pharmaceutical options to treat diabetes gets longer and longer.
The downside of this wealth of treatment options is that it can be difficult for health care providers to stay on top of the latest research and standards of care. Which medication is best for which patients? And what are the best medicines to prescribe that both lower blood glucose and reduce risk for cardiovascular disease?
Johns Hopkins Medicine endocrinologist ...
How many species of birds are there in the world? It depends on whose count you go by. The number could be as low as 10,000 or as high as 18,000. It's tough to standardize lists of species because the concept of a "species" itself is a little bit fuzzy.
That matters because conserving biodiversity requires knowing what diversity exists in the first place. So biologists, led by University of Utah doctoral candidate Monte Neate-Clegg of the School of Biological Sciences, set out to compare four main lists of bird species worldwide to find out how the lists differ--and why. They found that although the lists agree on most birds, disagreements in some regions ...
LAST 30 PRESS RELEASES:
[Press-News.org] All-in-one device uses microwave power for defense, medicine